{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:12:16Z","timestamp":1758823936622,"version":"3.41.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.pharep.2015.04.008","type":"journal-article","created":{"date-parts":[[2015,5,3]],"date-time":"2015-05-03T02:32:07Z","timestamp":1430620327000},"page":"1130-1134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Decrease of interleukin (IL)17A gene expression in leucocytes and in the amount of IL-17A protein in CD4+ T cells in children with Down Syndrome"],"prefix":"10.1007","volume":"67","author":[{"given":"Anna","family":"Jakubiuk-Tomaszuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Sobaniec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Rusak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Poskrobko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"N\u0119dzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Olchowik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Galicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"10","key":"10.1016\/j.pharep.2015.04.008_bib0130","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.pharep.2015.04.008_bib0135","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1084\/jem.20071978","article-title":"Regulation of inflammatory responses by IL-17F","volume":"205","author":"Yang","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharep.2015.04.008_bib0140","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cytogfr.2010.10.002","article-title":"IL-17 family member cytokines: regulation and function in innate immunity","volume":"21","author":"Reynolds","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.pharep.2015.04.008_bib0145","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.pharep.2015.04.008_bib0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni.1993","article-title":"Fate mapping of IL-17-producing T cells in inflammatory responses","volume":"12","author":"Hirota","year":"2011","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.pharep.2015.04.008_bib0155","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/519248","article-title":"Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance","volume":"81","author":"Prandini","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.pharep.2015.04.008_bib0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1744-313X.2010.00914.x","article-title":"Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome","volume":"37","author":"Cetiner","year":"2010","journal-title":"Int J Immunogenet"},{"issue":"5","key":"10.1016\/j.pharep.2015.04.008_bib0165","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1203\/PDR.0b013e3181d4ecc1","article-title":"Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help","volume":"67","author":"Verstegen","year":"2010","journal-title":"Pediatr Res"},{"issue":"41","key":"10.1016\/j.pharep.2015.04.008_bib0170","first-page":"49","article-title":"Assessment of cellular immunity in children with Down syndrome by determining the ratio of subpopulations of T lymphocytes CD3+, CD4+ and CD8+ in peripheral blood using flow cytometric method","volume":"20","author":"Jakubiuk-Tomaszuk","year":"2011","journal-title":"Neurol Dzieci\u0119ca"},{"issue":"11","key":"10.1016\/j.pharep.2015.04.008_bib0175","doi-asserted-by":"crossref","first-page":"e49130","DOI":"10.1371\/journal.pone.0049130","article-title":"Genome-wide expression analysis in Down syndrome: insight into immunodeficiency","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"year":"2012","series-title":"Assessment of efficiency of the immune system in children with Down syndrome","author":"Jakubiuk-Tomaszuk","key":"10.1016\/j.pharep.2015.04.008_bib0180"},{"issue":"4","key":"10.1016\/j.pharep.2015.04.008_bib0185","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000329527","article-title":"IL-17A and IL-17F expression in B lymphocytes","volume":"157","author":"Vazquez-Tello","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.pharep.2015.04.008_bib0190","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.pharep.2015.04.008_bib0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2249.2011.04335.x","article-title":"Infections and immunodeficiency in Down syndrome","volume":"164","author":"Ram","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.pharep.2015.04.008_bib0200","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.micinf.2010.05.007","article-title":"Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system","volume":"12","author":"Bloemers","year":"2010","journal-title":"Microbes Infect"},{"issue":"5","key":"10.1016\/j.pharep.2015.04.008_bib0205","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1203\/PDR.0b013e3181d4eca3","article-title":"Both normal memory counts and decreased naive cells favor intrinsic defect over early senescence of Down syndrome T lymphocytes","volume":"67","author":"Kusters","year":"2010","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.pharep.2015.04.008_bib0210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2008.11.009","article-title":"Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses","volume":"30","author":"Ishigame","year":"2009","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.pharep.2015.04.008_bib0215","doi-asserted-by":"crossref","first-page":"704","DOI":"10.4049\/jimmunol.1301687","article-title":"IL-17A produced by neutrophils protects against pneumonic plague through orchestrating IFN-\u03b3-activated macrophage programming","volume":"192","author":"Bi","year":"2014","journal-title":"J Immunol"},{"issue":"7188","key":"10.1016\/j.pharep.2015.04.008_bib0220","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharep.2015.04.008_bib0225","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1440-1754.2007.01229.x","article-title":"Autoantibodies in patients with Down syndrome: early senescence of the immune system or precocious markers for immunological diseases?","volume":"44","author":"da Rosa Utiyama","year":"2008","journal-title":"J Paediatr Child Health"},{"issue":"6","key":"10.1016\/j.pharep.2015.04.008_bib0230","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cell.2010.02.021","article-title":"Th17 and regulatory T cells in mediating and restraining inflammation","volume":"140","author":"Littman","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharep.2015.04.008_bib0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1734-1140(11)70396-6","article-title":"IL-17-expressing cells as a potential therapeutic target for treatment of immunological disorders","volume":"63","author":"Strz\u0119pa","year":"2011","journal-title":"Pharmacol Rep"},{"issue":"3","key":"10.1016\/j.pharep.2015.04.008_bib0240","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4049\/jimmunol.0902813","article-title":"Tumor microenvironments direct the recruitment and expansion of human Th17 cells","volume":"184","author":"Su","year":"2010","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.pharep.2015.04.008_bib0245","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tig.2005.02.012","article-title":"Transcriptional consequences of autosomal trisomy: primary gene dosage with complex downstream effects","volume":"21","author":"FitzPatrick","year":"2005","journal-title":"Trends Genet"},{"issue":"3","key":"10.1016\/j.pharep.2015.04.008_bib0250","first-page":"451","article-title":"Down's syndrome lymphoid cell lines exhibit increased adhesion due to the over-expression of lymphocyte function-associated antigen (LFA-1)","volume":"64","author":"Taylor","year":"1988","journal-title":"Immunology"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015000778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015000778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:03Z","timestamp":1752611763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2015.04.008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1734114015000778"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2015.04.008","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decrease of interleukin (IL)17A gene expression in leucocytes and in the amount of IL-17A protein in CD4+ T cells in children with Down Syndrome","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2015.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}